Pharma Flash - Layoffs and Mergers & Acquisitions - Plus Long COVID Study Results | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Wednesday, August 16, 2023

1. Emergent BioSolutions to Lay Off 400

2. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of Duchenne Muscular Dystrophy

3. PrecisionLife Identifies First Detailed Genetic Risk Factors For Long COVID

4. Lilly Completes Acquisition of DICE Therapeutics

5. Regeneron to Acquire Decibel Therapeutics

2025 Contract Services Directory and Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary print or
digital subscription

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.